title: Vitamin K supplementation in cystic fibrosis.
abstract: The relation between different doses of vitamin K supplementation, several bone markers, and PIVKA-II concentrations in cystic fibrosis (CF) patients compared to controls was evaluated. Results suggest that a increased vitamin K intake may have significant health benefits for children with CF.
authors: Department of Paediatrics, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, Netherlands.
authors: J H L
authors: JH
authors: van Hoorn
authors: J J E
authors: JJ
authors: Hendriks
authors: C
authors: C
authors: Vermeer
authors: P Ph
authors: PP
authors: Forget
mesh_terms: D015415:Biomarkers; D003550:Cystic Fibrosis / Q000097:blood / Q000150:complications*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D015675:Osteocalcin / Q000097:blood; D011498:Protein Precursors / Q000097:blood; D011516:Prothrombin; D014812:Vitamin K / Q000008:administration & dosage* / Q000627:therapeutic use; D014813:Vitamin K Deficiency / Q000209:etiology / Q000517:prevention & control
chemical_list: D015415:Biomarkers; D011498:Protein Precursors; D015675:Osteocalcin; D014812:Vitamin K; C008208:acarboxyprothrombin; D011516:Prothrombin